Synthesis and in vitro anticancer potential of new thiazole-containing derivatives of rhodanine
作者:Oleksandr V. Los、Vitalii O. Sinenko、Oleksandr L. Kobzar、Victor V. Zhirnov、Andriy I. Vovk、Volodymyr S. Brovarets
DOI:10.1007/s10593-023-03220-z
日期:2023.7
3-thiazol-2-yl-, 1,3-thiazol-4-yl-, and 1,3-thiazol-5-yl-containing derivatives of N-arylalkyl- and N-carboxyalkyl-substituted rhodanines were synthesized via Knoevenagel condensation and tested against 60 cancer cell lines of NCI panel. Among these compounds, N-[2-(4-methoxyphenyl)ethyl], N-[2-(3,4-dimethoxyphenyl)ethyl], and N-carboxydecyl rhodanines with 1,3-thiazol-4-yl or 1,3-thiazol-5-yl fragments were
合成了N-芳烷基-和N-羧烷基取代的绕丹宁的新含 1,3-噻唑-2-基-、1,3-噻唑-4-基-和 1,3-噻唑-5-基的衍生物通过Knoevenagel 浓缩并针对 NCI 小组的 60 种癌细胞系进行了测试。这些化合物中,N- [2-(4-甲氧基苯基)乙基]、N- [2-(3,4-二甲氧基苯基)乙基]和N-羧基癸基绕丹宁与1,3-噻唑-4-基或1, 3-噻唑-5-基片段是最有效的试剂,导致该组中超过 50% 的个体系生长受到抑制。它们的活性通过 50% 生长抑制的计算平均值来表征(GI 50)、总生长抑制 (TGI) 和 50% 细胞杀伤 (LC 50 )。对于整个组的敏感细胞系,带有N -[2-(4-甲氧基苯基)乙基]和N -[2-(3,4-二甲氧基苯基)乙基]取代基的化合物的平均 GI 50和平均 TGI 相似,并且具有N-羧基癸基取代基的化合物显着降低。含1,3-噻唑-5-基的N